SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-23-024740
Filing Date
2023-08-28
Accepted
2023-08-28 06:35:03
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A acrx20230823_defa14a.htm DEFA14A 9780
2 n01.jpg GRAPHIC 492069
3 n02.jpg GRAPHIC 469542
  Complete submission text file 0001437749-23-024740.txt   1334715
Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35068 | Film No.: 231210035
SIC: 2834 Pharmaceutical Preparations